Last reviewed · How we verify
NCT03464162
OnTrackNY With the Option of Social Network Meetings
NA trial testing Social Network Meetings in First Episode Psychosis. Withdrawn.
11 January 2019
Quick facts
| Lead sponsor | Lisa Dixon |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 11 April 2018 |
| Primary completion | 11 January 2019 |
| Estimated completion | 11 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Social Network Meetings
Conditions studied
- First Episode Psychosis — all drugs for First Episode Psychosis →
- Schizophrenia — all drugs for Schizophrenia →
Sponsor
Lisa Dixon
Who can join
16 and older, any sex, with First Episode Psychosis or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early intervention programs for psychosis help improve short-term treatment and recovery outcomes for individuals experiencing psychosis. OnTrackNY is a coordinated specialty care (CSC) program, developed to treat young adults within two years of experiencing a non-affective episode of psychosis. This project aims to expand the role of family engagement and support within the OnTrackNY model. Borrowing from the Needs Adapted and Open Dialogue models, the study team created a family therapy service that includes the client and members of his/her social network to navigate crises and assist in treatment planning. This service, Social Network Meetings, will be offered to individuals enrolled in the OnTrackNY@MHA program as an additional, voluntary, service option. The study proposes that the introduction of Social Network meetings may improve treatment and recovery outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03464162
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for First Episode Psychosis
Currently open trials in the same condition.
- NCT06774417 — Digital Strategies to Advance Help-Seeking - Aim 3 · NA · recruiting
- NCT06774430 — Digital Strategies to Advance Help-Seeking Aim 1 and 2 · recruiting
- NCT05310838 — Optimizing Engagement in Services for First-Episode Psychosis · NA · active not recruiting
- NCT04046497 — Artificial Intelligence to Measure Adherence to Oral Medication · Phase 4 · recruiting
- NCT04005378 — Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03464162 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lisa Dixon
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03464162.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing